Os et intestin. Prise en charge des ostéopathies associées aux pathologies intestinales

Leslie, 2009, Body mass and composition effect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study, Inflamm Bowel Dis, 15, 39, 10.1002/ibd.20541 Schoon Ej, 2000, Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort, Scand J Gastroenterol Suppl, 232, 43 Jahnsen, 1997, Bone mineral density is reduced in patients with Croh's disease but not in patients with ulcerative colitis: a population based study, Gut, 40, 313, 10.1136/gut.40.3.313 Tsai, 2015, Risks and predictors of osteoporosis in patients with inflammatory bowel diseases in an Asian population: a nationwide population-based cohort study, Int J Clin Pract, 69, 235, 10.1111/ijcp.12526 Targownik, 2012, Longitudinal change in bone mineral density in a population-based cohort of patients with inflammatory bowel disease, Calcif Tissue Int, 91, 356, 10.1007/s00223-012-9650-1 Roux, 1995, Bone loss in patients with inflammatory bowel disease: a prospective study, Osteoporos Int, 5, 156, 10.1007/BF02106094 Bernstein, 2000, The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study, Ann Intern Med, 133, 795, 10.7326/0003-4819-133-10-200011210-00012 Vestergaard, 2002, Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark, Am J Epidemiol, 156, 1, 10.1093/aje/kwf007 Card, 2004, Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study, Gut, 53, 251, 10.1136/gut.2003.026799 Ashcroft, 2003, Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin, Immunity, 19, 849, 10.1016/S1074-7613(03)00326-1 Moschen, 2005, The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss, Gut, 54, 479, 10.1136/gut.2004.044370 Ghosh, 1994, Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis, Gastroenterology, 107, 1031, 10.1016/0016-5085(94)90227-5 Turk, 2009, Proinflammatory cytokines and receptor activator of nuclear factor kappaB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohn's disease, Eur J Gastroenterol Hepatol, 21, 159, 10.1097/MEG.0b013e3283200032 Abitbol, 1997, Bone assessment in patients with ileal pouch-anal anastomosis for inflammatory bowel disease, Br J Surg, 84, 1551, 10.1002/bjs.1800841117 Targownik, 2014, Prevalence of and outcomes associated with corticosteroid prescription in inflammatory bowel disease, Inflamm Bowel Dis, 20, 622, 10.1097/MIB.0000000000000008 Weinstein, 2010, Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity, Bone, 46, 564, 10.1016/j.bone.2009.06.030 Canalis, 2007, Glucocorticoid-induced osteoporosis: pathophysiology and therapy, Osteoporos Int, 18, 1319, 10.1007/s00198-007-0394-0 Bernstein, 2003, The association between corticosteroid use and development of fractures among IBD patients in a population-based database, Am J Gastroenterol, 98, 1797, 10.1111/j.1572-0241.2003.07590.x Abraham, 2014, Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients, Dig Dis Sci, 59, 1878, 10.1007/s10620-014-3102-x Majumdar, 2013, Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study, Osteoporos Int, 9, 2493, 10.1007/s00198-013-2352-3 Targownik, 2013, Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis, Clin Gastroenterol Hepatol, 11, 278, 10.1016/j.cgh.2012.10.022 Mauro, 2007, Evaluation of densitometric bone-muscle relationships in Crohn's disease, Bone, 40, 1610, 10.1016/j.bone.2007.02.026 Lima, 2015, Risk factors for osteoporosis in inflammatory bowel disease patients, World J Gastrointest Pathophysiol, 6, 210, 10.4291/wjgp.v6.i4.210 Leslie, 2008, Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study, Am J Gastroenterol, 103, 1451, 10.1111/j.1572-0241.2007.01753.x Navaneethan, 2013, Impact of inflammatory bowel disease on post-cholecystectomy complications and hospitalization costs: a Nationwide Inpatient Sample study, J Crohns Colitis, 7, e164, 10.1016/j.crohns.2012.07.032 Gupta, 2013, Bone loss in patients with the ileostomy and ileal pouch for inflammatory bowel disease, Gastroenterol Rep (Oxf), 1, 159, 10.1093/gastro/got030 Gupta, 2014, Frequency, risk factors, and adverse sequelae of bone loss in patients with ostomy for inflammatory bowel diseases, Inflamm Bowel Dis, 20, 259, 10.1097/01.MIB.0000439065.92211.d3 Bernstein, 2003, AGA technical review on osteoporosis in gastrointestinal diseases, Gastroenterology, 124, 795, 10.1053/gast.2003.50106 Briot, 2014, 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, 81, 493, 10.1016/j.jbspin.2014.10.001 Targownik, 2013, Inflammatory bowel disease and the risk of fracture after controlling for FRAX, J Bone Miner Res, 28, 1007, 10.1002/jbmr.1848 Melek, 2014, Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review, Clin Gastroenterol Hepatol, 12, 10.1016/j.cgh.2013.08.024 Mauro, 2007, Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients, Can J Gastroenterol, 21, 637, 10.1155/2007/216162 Franchimont, 2004, Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease, Aliment Pharmacol Ther, 20, 607, 10.1111/j.1365-2036.2004.02152.x Mustalahti, 1999, Osteopenia in patients with clinically silent coeliac disease warrants screening, Lancet, 354, 744, 10.1016/S0140-6736(99)01990-X Kemppainen, 1999, Osteoporosis in adult patients with celiac disease, Bone, 24, 249, 10.1016/S8756-3282(98)00178-1 Cellier, 2000, Severe osteopenia in symptom-free adults with a childhood diagnosis of coeliac disease, Lancet, 355, 806, 10.1016/S0140-6736(99)04855-2 Olmos, 2008, Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease, Dig Liver Dis, 40, 46, 10.1016/j.dld.2007.09.006 Ludvigsson, 2007, Coeliac disease and the risk of fractures – a general population-based cohort study, Aliment Pharmacol Ther, 25, 273, 10.1111/j.1365-2036.2006.03203.x Valdimarsson, 2000, Three years’ follow-up of bone density in adult coeliac disease: significance of secondary hyperparathyroidism, Scand J Gastroenterol, 35, 274, 10.1080/003655200750024146 Selby, 1999, Bone loss in celiac disease is related to secondary hyperparathyroidism, J Bone Miner Res, 14, 652, 10.1359/jbmr.1999.14.4.652 Kontakou, 1995, Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease, Scand J Gastroenterol, 30, 456, 10.3109/00365529509093307 Fornari, 1998, Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia?, Am J Gastroenterol, 93, 413, 10.1111/j.1572-0241.1998.00413.x Mora, 1999, Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients, Am J Gastroenterol, 94, 398, 10.1111/j.1572-0241.1999.867_r.x Gardner, 1951, A genetic and clinical study of intestinal polyposis: a predisposing factor for carcinoma of the colon, Am J Hum Gen, 3, 163 Touré, 2004, Intérêt des signes maxillo-faciaux dans le diagnostic du syndrome de Gardner, Rev Stomatol Chir Maxilofac, 105, 177, 10.1016/S0035-1768(04)72299-8